To the shareholders and partners of Zhongyuan Biotechnology holding Group: 

On September 6, 2019, Zhongyuan Biotechnology Holdings Group (Zhongyuan Group) has completed all the IPO application documents and procedures required by SEC (Securities and Exchange Commission, U S Securities and Exchange Commission). After being examined and approved by SEC and approved by FINRA)of the United States Financial Regulatory Authority, the final stock symbol will be obtained.

Thanks to the efforts of all colleagues in the company, as well as the help and support of friends from all walks of life, Zhongyuan Group will go all out to strive for continuously increasing performance and opening higher share prices to all shareholders!

Friends who are concerned about our growth can learn more about the company structure, main business section and financial situation of Zhongyuan Group one by one through the "6-k" document published by SEC.

All the documents submitted by the company have been strictly examined by international lawyers, auditors and accountants to ensure that the materials submitted are true and correct. The signature of the international auditor firm is as follows:

Thank you for your support and companionship. We will make great achievements together in the future.